• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Penile traction device shows benefit in men post-radical prostatectomy

Article

Interim results from a clinical trial of a next-generation penile traction therapy device were encouraging and demonstrated statistically significant increases in penile length and a smaller reduction in erectile function among post-prostatectomy men who were treated with the device, known as RestoreX, according to PathRight Medical.

Interim results from a clinical trial of a next-generation penile traction therapy device were encouraging and demonstrated statistically significant increases in penile length and a smaller reduction in erectile function among post-prostatectomy men who were treated with the device, known as RestoreX, according to PathRight Medical.

In the trial, men started using RestoreX 1 month after surgery for 5 months. At the 6-month follow-up, men had gained 2 cm in length (p<.01) and had a reduction in erectile function of -0.5 points from baseline compared to –9.0 in controls (p=.02) using the International Index of Erectile Function Questionnaire. The study, led by Landon Trost, MD, of the Male Fertility and Peyronie’s Clinic in Orem, UT, was presented at the 2019 Sexual Medicine Society of North America annual fall scientific meeting in Nashville, TN.

RestoreX is also used to correct curvature and lost length associated with Peyronie’s disease. It registered with the FDA.

Related Videos
Dr. Landon Trost in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.